AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Scope & Guideline

Championing Innovative Discoveries in Amyloidosis

Introduction

Welcome to your portal for understanding AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1350-6129
PublisherTAYLOR & FRANCIS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1994 to 2024
AbbreviationAMYLOID / Amyloid-J. Protein Fold. Disord.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND

Aims and Scopes

The AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS focuses on advancing the understanding of amyloidosis and protein folding disorders through innovative research. The journal serves as a platform for the dissemination of findings that improve diagnosis, treatment, and management of amyloid-related diseases.
  1. Understanding Amyloid Diseases:
    The journal emphasizes the study of various forms of amyloidosis, including AL, ATTR, and AA amyloidosis, exploring their molecular mechanisms, clinical presentations, and diagnostic challenges.
  2. Innovative Diagnostic Techniques:
    Methodologies such as mass spectrometry, imaging techniques, and biomarker discovery are frequently discussed, highlighting advancements in the detection and characterization of amyloid deposits.
  3. Therapeutic Advances:
    Research on treatment modalities, including pharmacological interventions like tafamidis and patisiran, is a core area, focusing on their efficacy, safety, and pharmacodynamics in different patient populations.
  4. Multidisciplinary Approaches:
    The journal promotes a multidisciplinary perspective, integrating insights from genetics, pathology, neurology, cardiology, and proteomics to provide a comprehensive understanding of amyloidosis.
  5. Patient-Centric Research:
    Studies that address patient experiences, outcomes, and the impact of amyloidosis on quality of life are essential, emphasizing the importance of patient-reported outcomes in clinical research.
The landscape of amyloidosis research is evolving, with several emerging themes gaining traction in recent publications. This reflects a growing focus on precision medicine, novel therapeutic strategies, and improved diagnostic techniques.
  1. Precision Medicine Approaches:
    There is a significant trend towards personalized treatment strategies for amyloidosis patients, using genetic profiling and biomarkers to tailor therapies, particularly in hereditary forms of the disease.
  2. Neurodegenerative Links:
    Research increasingly explores the connections between amyloidosis and neurodegenerative diseases, particularly in understanding the role of amyloid deposits in conditions like Alzheimer's disease.
  3. Longitudinal Studies and Real-World Evidence:
    Emerging trends include a focus on longitudinal studies that assess treatment outcomes over time, providing valuable real-world evidence on the effectiveness of therapies.
  4. Innovative Imaging Techniques:
    Advancements in imaging modalities, such as PET and MRI, are becoming increasingly relevant for both diagnosis and monitoring of disease progression in amyloidosis.
  5. Patient-Reported Outcomes and Quality of Life:
    There is a growing emphasis on incorporating patient-reported outcomes into research, reflecting a broader recognition of the importance of quality of life for individuals living with amyloidosis.

Declining or Waning

While the journal continues to expand its focus on numerous aspects of amyloidosis, certain themes appear to be declining in prominence. This may reflect shifts in research priorities or advancements in understanding that lessen the need for certain investigations.
  1. Historical Case Studies:
    There has been a noticeable reduction in publications focusing on historical case reports of amyloidosis, suggesting a move towards more contemporary research and clinical trials.
  2. Basic Science of Protein Folding:
    Research primarily centered on fundamental aspects of protein folding without direct clinical or therapeutic implications seems to be waning, as the journal prioritizes studies with immediate clinical relevance.
  3. Epidemiological Studies:
    While still present, there is a decrease in the frequency of large-scale epidemiological studies on amyloidosis prevalence, indicating a possible shift towards more localized, specific studies or clinical trials.
  4. Iatrogenic Amyloidosis Reports:
    Reports concerning iatrogenic forms of amyloidosis, although significant, are appearing less frequently, which may reflect advancements in clinical practices that reduce such occurrences.
  5. Animal Models in Amyloidosis Research:
    Research utilizing animal models to study amyloidosis mechanisms is declining, possibly as the field shifts towards human-centric studies that yield more applicable results.

Similar Journals

Osteoarthritis and Cartilage

Transforming Insights into Therapeutic Solutions
Publisher: ELSEVIER SCI LTDISSN: 1063-4584Frequency: 12 issues/year

Osteoarthritis and Cartilage, published by ELSEVIER SCI LTD, stands as a leading journal in the fields of Biomedical Engineering, Orthopedics and Sports Medicine, and Rheumatology. With an impressive impact factor reflective of its significant contribution to these domains, the journal has established a prominent place within the academic community since its inception in 1993. As evidenced by its Q1 quartile rankings across multiple categories, the journal is recognized for its high-quality peer-reviewed research that pushes the boundaries of knowledge regarding osteoarthritis and related cartilage disorders. Its rankings in Scopus, placing it among the top 2% of journals in Orthopedics and Sports Medicine and the top 7% in Rheumatology, further underscore its pivotal role in advancing clinical and biomechanical understandings of joint health. While open access options are not currently available, the journal encourages submissions that explore innovative solutions and therapeutic approaches to musculoskeletal conditions, fostering a collaborative environment among researchers, professionals, and students alike. Situated in the heart of London, it serves as a critical repository for cutting-edge research shaping the future of patient care and bone health.

Case Reports in Pediatrics

Transforming Pediatric Practice Through Shared Experiences.
Publisher: HINDAWI LTDISSN: 2090-6803Frequency: 1 issue/year

Case Reports in Pediatrics is a distinguished journal dedicated to the publication of high-quality case reports that illuminate specific pediatric clinical challenges and advancements. Published by HINDAWI LTD, this journal has established itself as an essential resource in the field of pediatric medicine, offering an open-access platform since 2011 to ensure that researchers, healthcare professionals, and students have unrestricted access to valuable insights. With an ISSN of 2090-6803 and an E-ISSN of 2090-6811, the journal aims to foster knowledge exchange and further the understanding of pediatric healthcare practices. This publication not only encourages the sharing of unique and rare case studies but also promotes best practices and innovative methodologies. In a rapidly evolving field, Case Reports in Pediatrics serves as a vital tool for professionals seeking to enhance patient care and inform clinical decision-making.

Prion

Advancing the frontiers of prion research.
Publisher: TAYLOR & FRANCIS INCISSN: 1933-6896Frequency: 1 issue/year

Prion is a pioneering open-access journal published by Taylor & Francis Inc, dedicated to the dynamic field of prion research. With an ISSN of 1933-6896 and an E-ISSN of 1933-690X, this journal serves as a vital platform for the dissemination of cutting-edge findings related to prion biology, infectious diseases, and neurodegenerative disorders. Since its transition to open access in 2019, Prion has become increasingly accessible to a global audience, encouraging collaboration and knowledge sharing among researchers, professionals, and students. The journal holds a notable impact in various categories, with its 2023 quartile rankings showcasing Q3 statuses in Biochemistry and Cell Biology, Q4 in Cellular and Molecular Neuroscience, and Q2 in Infectious Diseases. Despite a lack of H-index, its diverse research contributions are underscored by its Scopus rankings, which highlight its significance within the biomedical field. With published works spanning from 2007 to 2024, Prion continues to be a critical resource for those engaged in the investigation of prion-related phenomena and their implications on health and disease.

Tremor and Other Hyperkinetic Movements

Unlocking insights into tremors and movement disorders.
Publisher: UBIQUITY PRESS LTDISSN: 2160-8288Frequency: 1 issue/year

Tremor and Other Hyperkinetic Movements is a pioneering open-access journal published by UBIQUITY PRESS LTD, dedicated to advancing the understanding of hyperkinetic movement disorders, including tremors. Since its inception in 2011, the journal has provided a vital platform for researchers, professionals, and students within the fields of neurology and movement disorders to share innovative findings, case studies, and clinical trials. With its contributions spanning from 2012 to 2024, the journal emphasizes high-quality research and fosters collaboration within the medical community. Although it holds a Scopus rank of 156 in the field of Medicine, particularly Cardiology and Cardiovascular Medicine, its value extends beyond metrics, inviting interdisciplinary dialogue about the mechanisms, treatments, and implications of these complex disorders. By offering unrestricted access to its content, Tremor and Other Hyperkinetic Movements ensures that crucial knowledge reaches a global audience, thus enabling advancements in clinical practices and improved patient outcomes.

BMC GASTROENTEROLOGY

Your Gateway to Cutting-Edge Gastrointestinal Discoveries
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Gastroenterology is a premier open-access journal published by BMC, dedicated to disseminating high-quality research in the field of gastroenterology. Established in 2001 and headquartered in the United Kingdom, this journal aims to enhance the understanding of gastrointestinal disorders through innovative research, reviews, and clinical studies. With an impressive impact factor and ranking within the Q2 category in gastroenterology and miscellaneous medicine for 2023, BMC Gastroenterology plays a critical role in advancing knowledge and practices in the field. The journal's commitment to open access ensures that researchers, professionals, and students worldwide can freely access and share vital findings and insights. Encouraging collaboration and knowledge transfer, BMC Gastroenterology is an essential resource for those dedicated to improving gastrointestinal health and outcomes.

Epilepsy & Behavior Reports

Fostering Collaboration for a Deeper Understanding of Epilepsy
Publisher: ELSEVIER SCIENCE INCISSN: Frequency: 1 issue/year

Epilepsy & Behavior Reports, a distinguished journal published by ELSEVIER SCIENCE INC, specializes in the latest research and developments in the field of epilepsy and related behavioral conditions. Since its inception in 2019 as a fully Open Access journal, it has carved a niche for itself within the scientific community, providing an essential platform for researchers and clinicians focused on behavioral neuroscience and neurology. The journal's commitment to disseminating high-quality research is reflected in its current rankings within Scopus, placing it within the Q3 category for Behavioral Neuroscience and Clinical Neurology, underscoring its relevance to emerging trends in these fields. Located in the heart of New York, the journal strives to foster collaboration and innovation, making it a vital resource for academics, practitioners, and students eager to advance their understanding of epilepsy and its behavioral implications. The convergence of expertise and research in Epilepsy & Behavior Reports promises to illuminate crucial aspects of neurological health, driving forward the discourse that shapes future treatment and understanding of epilepsy.

Investigative and Clinical Urology

Advancing urological science for a healthier tomorrow.
Publisher: KOREAN UROLOGICAL ASSOCISSN: 2466-0493Frequency: 6 issues/year

Investigative and Clinical Urology is an esteemed open-access journal dedicated to advancing research and clinical practice in the field of urology. Published by the Korean Urological Association, this journal serves as a crucial platform for sharing innovative findings and discussions on urological science, treatments, and technologies. With an ISSN of 2466-0493 and an E-ISSN of 2466-054X, it has established its presence in the academic community since transitioning to open access in 2016. Positioned in the Q2 quartile of urology journals for 2023 and ranked 39th out of 120 in Scopus's urology category, it reflects a strong impact in the field with a 67th percentile ranking. This journal not only facilitates broad accessibility to high-quality research but also fosters collaboration and dialogue among researchers, professionals, and students interested in the latest advancements in urology. Operating from Seoul, South Korea, Investigative and Clinical Urology remains a pivotal resource for anyone seeking to enhance their understanding and practice in urological medicine.

CURRENT OPINION IN PHARMACOLOGY

Pioneering Perspectives in Pharmacological Innovation
Publisher: ELSEVIER SCI LTDISSN: 1471-4892Frequency: 6 issues/year

Current Opinion in Pharmacology, an esteemed journal published by Elsevier Science Ltd, encompasses the vital field of pharmacology and drug discovery. With a solid impact factor and recognized as a Q1 journal in both Drug Discovery and Pharmacology categories for 2023, it serves as a premier platform for researchers and professionals to share innovative insights, discuss emerging trends, and explore the complexities of drug development and therapeutic applications. Established in 2001 and running through 2024, this journal provides a critical overview of advances in the field, aiming to inform and inspire the next generation of pharmacological research. Despite lacking Open Access options, it maintains a high standard of scholarly excellence, ensuring that the content remains impactful and relevant to its readers. The journal is based in the Netherlands, representing a key contributor to the academic landscape in pharmacology.

HPB

Advancing knowledge in Gastroenterology and Hepatology.
Publisher: ELSEVIER SCI LTDISSN: 1365-182XFrequency: 12 issues/year

HPB is a premier journal dedicated to advancing the fields of Gastroenterology and Hepatology, published by Elsevier Science Ltd. With an impressive impact factor reflective of its high-quality research output, HPB has earned its place as a Q1 journal in Gastroenterology and Q2 in Hepatology as of 2023. The journal, available in both print and electronic formats (ISSN: 1365-182X; E-ISSN: 1477-2574), serves as a vital platform for multidisciplinary research, encompassing clinical and experimental studies, aimed at improving patient care and outcomes related to liver and biliary diseases. Since its inception in 2000, HPB has published influential articles that have shaped practice and policy in the field. Located in the United Kingdom, at 125 London Wall, London EC2Y 5AS, the journal is poised to continue its mission of fostering innovation and collaboration among researchers, healthcare professionals, and academicians worldwide.

JOURNAL OF PROTEOME RESEARCH

Illuminating the Path of Biochemical Discovery
Publisher: AMER CHEMICAL SOCISSN: 1535-3893Frequency: 6 issues/year

JOURNAL OF PROTEOME RESEARCH is a premier publication in the field of proteomics, disseminating cutting-edge research and methodologies that drive advancements in biochemistry and molecular biology. Published by the American Chemical Society, this esteemed journal boasts a robust impact, as evidenced by its Q1 rankings in both Biochemistry and miscellaneous Chemistry categories for 2023. With a reputation bolstered by a solid Scopus ranking—#64 out of 408 in General Chemistry and #80 out of 438 in Biochemistry—the journal serves as an essential resource for researchers, professionals, and students aiming to deepen their understanding of protein functions and interactions in biological systems. Although it does not operate under an open-access model, the JOURNAL OF PROTEOME RESEARCH remains a critical platform for scholarly discourse, committed to publishing high-quality, peer-reviewed articles through 2024 and beyond. Scholars are encouraged to engage with the pioneering studies and reviews that shape the future of proteomics.